Effect of SLCO Polymorphisms on High-Dose Methotrexate Clearance in Pediatric Oncology Patients |
Vanderbilt University Medical Center |
Cure4Cam Childhood Cancer Foundation |
Natural Killer T cells with an IL-15-armored GD2-specific CAR for Children with Neuroblastoma |
Baylor College of Medicine |
Cure4Cam Childhood Cancer Foundation, Tap Cancer Out, Turn It Gold, Chance for Life |
Novel Approaches for Epigenetic Therapy for Relapsed Acute Lymphoblastic Leukemia |
The Johns Hopkins University School of Medicine |
Cure4Cam Childhood Cancer Foundation |
Targeting Protein Translation to Antagonize MYC-driven Neuroblastoma |
Children’s Hospital of Philadelphia |
Cure4Cam Childhood Cancer Foundation |
Identification and Targeting of Microenvironmental Factors Controlling Pediatric Leukemia |
New York University School of Medicine |
Cure4Cam Childhood Cancer Foundation |
Improving Immune-Mediated Oncolytic Viral Therapy: Engineering Tumor Vaccine Elements into the Virus |
Research Institute at Nationwide Children's Hospital |
Cure4Cam Childhood Cancer Foundation, Flashes of Hope |
Targeting Microenvironmental Support of Acute Lymphoblastic Leukemia |
University of Rochester |
Cure4Cam Childhood Cancer Foundation |
CD47-blocking Oncolytic Vaccinia Viruses as Biotherapeutics for Pediatric Solid Tumors |
St. Jude Children’s Research Hospital |
Cure4Cam Childhood Cancer Foundation |
Optimizing Bispecific Antibody Therapy for Acute Leukemias |
Fred Hutchinson Cancer Research Center |
Cure4Cam Childhood Cancer Foundation |
Antibody Targeted Natural Killer Cell-Derived Extracellular Vesicles for the Treatment of Childhood Acute Lymphoblastic Leukemia and Neuroblastoma |
Children’s Hospital Los Angeles |
Cure4Cam Childhood Cancer Foundation, Flashes of Hope |